Log in
Enquire now
‌

US Patent 10927346 Enhanced immune effector cells and use thereof

Patent 10927346 was granted and assigned to Fate Therapeutics Inc on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Date Filed
September 19, 2019
0
Date of Patent
February 23, 2021
0
Patent Application Number
16576411
0
Patent Citations Received
‌
US Patent 12122846 Chimeric antigen receptor for tumor targeting
0
‌
US Patent 11591381 Gene-edited natural killer cells
0
‌
US Patent 11661459 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
0
‌
US Patent 11365394 Enhanced immune effector cells and use thereof
‌
US Patent 11883432 Chimeric antigen receptor system with adaptable receptor specificity
0
‌
US Patent 12104178 DHFR tunable protein regulation
0
‌
US Patent 11459372 Gene-edited natural killer cells
Patent Inventor Names
Bahram Valamehr
0
Jode Goodridge
0
Ryan Bjordahl
0
Tom Tong Lee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10927346
0
Patent Primary Examiner
‌
Marcia S Noble
0

Find more entities like US Patent 10927346 Enhanced immune effector cells and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.